Systemic Inflammatory Index Dynamics At 6 Weeks As An Early Surrogate For Clinical Benefit In Patients With Nsclc And Pd-L1>=50% Expression Treated With Pembrolizumab: Data From The Real-Life Practice
Pembrolizumab
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Systemic Inflammatory Index Dynamics At 6 Weeks As An Early Surrogate For Clinical Benefit In Patients With Nsclc And Pd-L1>=50% Expression Treated With Pembrolizumab: Data From The Real-Life Practice ### Output: Pembrolizumab